Cadre (NYSE:CDRE) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full
Cadre (NYSE:CDRE) reported Q2 CY2026 revenue of $207.1 million, up 31.8% year on year and above market expectations, and said full-year revenue guidance of $759 million at the midpoint is 2.9% above analysts’ estimates. GAAP EPS was $0.26, 18% above consensus. The stock rose 4.7% to $32.49 after results.
How this was made
The 30-second read
Why it matters
The key tradable inputs are the Q2 revenue beat, GAAP EPS beat, and the $759M full-year revenue guidance midpoint versus estimates. The main risk signal in the article is EPS down year over year alongside dilution from a prior equity raise.
Market read
A revenue and GAAP EPS beat with above-consensus full-year revenue guidance can drive continued momentum, but EPS decline and dilution are potential valuation headwinds.
What to watch
The text emphasizes operating margin improvement but does not quantify cash flow or backlog; traders may need to verify whether the revenue acceleration is durable or one-off.
Background
Cadre, formerly Safariland, makes safety and survivability equipment for first responders and reported Q2 CY2026 results with full-year revenue guidance.
Ticker impact
Cadre reported Q2 CY2026 revenue up 31.8% to $207.1M and guided full-year revenue to $759M midpoint, beating estimates.
Likely supports continued post-earnings bid, but follow-through depends on whether investors focus on revenue beat versus EPS decline and share-count dilution.
The article provides concrete Q2 revenue and GAAP EPS versus consensus plus a specific full-year revenue midpoint. It also flags EPS down year over year and a large share-count increase, which can temper enthusiasm despite the revenue outperformance.
Market effects
Strength in safety and survivability equipment demand could be read-across positive for industrials/defense-adjacent peers, though the article is company-specific.
No specific regional spillover beyond US defense/industrial sentiment.
Limited; no international contracts or geopolitical triggers mentioned.
Counterpoint
Despite the revenue beat, EPS declined year over year and the article notes a 57.9% share-count increase, which can cap valuation support if margins or tax/interest effects persist.
Key entities
- companyCadre
NYSE-listed aerospace and defense safety and survivability equipment provider reporting Q2 CY2026 results and full-year revenue guidance.
